Proteasomal interaction as a critical activity modulator of the human constitutive androstane receptor

Tao Chen, Elizabeth M. Laurenzana, Denise M. Coslo, Fengming Chen, Curtis John Omiecinski

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The CAR (constitutive androstane receptor; NR1I3) is a critical xenobiotic sensor that regulates xenobiotic metabolism, drug clearance, energy and lipid homoeostasis, cell proliferation and development. Although constitutively active, in hepatocytes CAR is normally held quiescent through a tethering mechanism in the cytosol, anchored to a protein complex that includes several components, including heat-shock protein 90. Release and subsequent nuclear translocation of CAR is triggered through either direct binding to ligand activators such as CITCO {6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5- carbaldehyde O-(3,4-dichlorobenzyl)oxime} or through indirect chemical activation, such as with PB (phenobarbital). In the present study, we demonstrate that proteasomal inhibition markedly disrupts CAR function, repressing CAR nuclear trafficking, disrupting CAR's interaction with nuclear co-activators and inhibiting induction of CAR target gene responses in human primary hepatocytes following treatment with either PB or CITCO. Paradoxically, these effects occur following accumulation of ubiquitinatedhCAR (human CAR). Furthermore, a non-proteolytic function was indicated by its interaction with a SUG1 (suppressor for Gal1), a subunit of the 26S proteasome. Taken together, these data demonstrate that the proteasome complex functions at multiple levels to regulate the functional biology of hCAR activity.

Original languageEnglish (US)
Pages (from-to)95-107
Number of pages13
JournalBiochemical Journal
Volume458
Issue number1
DOIs
StatePublished - Jan 15 2014

Fingerprint

Xenobiotics
Phenobarbital
Modulators
Hepatocytes
HSP90 Heat-Shock Proteins
Proteasome Endopeptidase Complex
Cytosol
Homeostasis
Cell Proliferation
Cell proliferation
Ligands
Lipids
Metabolism
Genes
Chemical activation
Pharmaceutical Preparations
Proteins
Sensors
constitutive androstane receptor
ATP dependent 26S protease

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Chen, Tao ; Laurenzana, Elizabeth M. ; Coslo, Denise M. ; Chen, Fengming ; Omiecinski, Curtis John. / Proteasomal interaction as a critical activity modulator of the human constitutive androstane receptor. In: Biochemical Journal. 2014 ; Vol. 458, No. 1. pp. 95-107.
@article{7e3664a9d5b14a5e931db4a93c10b0c4,
title = "Proteasomal interaction as a critical activity modulator of the human constitutive androstane receptor",
abstract = "The CAR (constitutive androstane receptor; NR1I3) is a critical xenobiotic sensor that regulates xenobiotic metabolism, drug clearance, energy and lipid homoeostasis, cell proliferation and development. Although constitutively active, in hepatocytes CAR is normally held quiescent through a tethering mechanism in the cytosol, anchored to a protein complex that includes several components, including heat-shock protein 90. Release and subsequent nuclear translocation of CAR is triggered through either direct binding to ligand activators such as CITCO {6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5- carbaldehyde O-(3,4-dichlorobenzyl)oxime} or through indirect chemical activation, such as with PB (phenobarbital). In the present study, we demonstrate that proteasomal inhibition markedly disrupts CAR function, repressing CAR nuclear trafficking, disrupting CAR's interaction with nuclear co-activators and inhibiting induction of CAR target gene responses in human primary hepatocytes following treatment with either PB or CITCO. Paradoxically, these effects occur following accumulation of ubiquitinatedhCAR (human CAR). Furthermore, a non-proteolytic function was indicated by its interaction with a SUG1 (suppressor for Gal1), a subunit of the 26S proteasome. Taken together, these data demonstrate that the proteasome complex functions at multiple levels to regulate the functional biology of hCAR activity.",
author = "Tao Chen and Laurenzana, {Elizabeth M.} and Coslo, {Denise M.} and Fengming Chen and Omiecinski, {Curtis John}",
year = "2014",
month = "1",
day = "15",
doi = "10.1042/BJ20130685",
language = "English (US)",
volume = "458",
pages = "95--107",
journal = "Biochemical Journal",
issn = "0264-6021",
publisher = "Portland Press Ltd.",
number = "1",

}

Proteasomal interaction as a critical activity modulator of the human constitutive androstane receptor. / Chen, Tao; Laurenzana, Elizabeth M.; Coslo, Denise M.; Chen, Fengming; Omiecinski, Curtis John.

In: Biochemical Journal, Vol. 458, No. 1, 15.01.2014, p. 95-107.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Proteasomal interaction as a critical activity modulator of the human constitutive androstane receptor

AU - Chen, Tao

AU - Laurenzana, Elizabeth M.

AU - Coslo, Denise M.

AU - Chen, Fengming

AU - Omiecinski, Curtis John

PY - 2014/1/15

Y1 - 2014/1/15

N2 - The CAR (constitutive androstane receptor; NR1I3) is a critical xenobiotic sensor that regulates xenobiotic metabolism, drug clearance, energy and lipid homoeostasis, cell proliferation and development. Although constitutively active, in hepatocytes CAR is normally held quiescent through a tethering mechanism in the cytosol, anchored to a protein complex that includes several components, including heat-shock protein 90. Release and subsequent nuclear translocation of CAR is triggered through either direct binding to ligand activators such as CITCO {6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5- carbaldehyde O-(3,4-dichlorobenzyl)oxime} or through indirect chemical activation, such as with PB (phenobarbital). In the present study, we demonstrate that proteasomal inhibition markedly disrupts CAR function, repressing CAR nuclear trafficking, disrupting CAR's interaction with nuclear co-activators and inhibiting induction of CAR target gene responses in human primary hepatocytes following treatment with either PB or CITCO. Paradoxically, these effects occur following accumulation of ubiquitinatedhCAR (human CAR). Furthermore, a non-proteolytic function was indicated by its interaction with a SUG1 (suppressor for Gal1), a subunit of the 26S proteasome. Taken together, these data demonstrate that the proteasome complex functions at multiple levels to regulate the functional biology of hCAR activity.

AB - The CAR (constitutive androstane receptor; NR1I3) is a critical xenobiotic sensor that regulates xenobiotic metabolism, drug clearance, energy and lipid homoeostasis, cell proliferation and development. Although constitutively active, in hepatocytes CAR is normally held quiescent through a tethering mechanism in the cytosol, anchored to a protein complex that includes several components, including heat-shock protein 90. Release and subsequent nuclear translocation of CAR is triggered through either direct binding to ligand activators such as CITCO {6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5- carbaldehyde O-(3,4-dichlorobenzyl)oxime} or through indirect chemical activation, such as with PB (phenobarbital). In the present study, we demonstrate that proteasomal inhibition markedly disrupts CAR function, repressing CAR nuclear trafficking, disrupting CAR's interaction with nuclear co-activators and inhibiting induction of CAR target gene responses in human primary hepatocytes following treatment with either PB or CITCO. Paradoxically, these effects occur following accumulation of ubiquitinatedhCAR (human CAR). Furthermore, a non-proteolytic function was indicated by its interaction with a SUG1 (suppressor for Gal1), a subunit of the 26S proteasome. Taken together, these data demonstrate that the proteasome complex functions at multiple levels to regulate the functional biology of hCAR activity.

UR - http://www.scopus.com/inward/record.url?scp=84892914168&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892914168&partnerID=8YFLogxK

U2 - 10.1042/BJ20130685

DO - 10.1042/BJ20130685

M3 - Article

VL - 458

SP - 95

EP - 107

JO - Biochemical Journal

JF - Biochemical Journal

SN - 0264-6021

IS - 1

ER -